SCHEDULE 13G

Company

Galmed Pharmaceuticals Ltd.

Filed

July 28, 2020

Accession Number

0001079973-20-000628

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →